Blood cholesterol level and risk of stroke in community-based or worksite cohort studies: A review of Japanese cohort studies in the past 20 years

Keio Journal of Medicine

Volumn 61, Issue 3, 2012, Pages 79-88

  Tanaka, Taichiro ^a   Okamura, Tomonori ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Cerebral infarction; Cholesterol; Cohort studies; Intracerebral hemorrhage; Stroke

Indexed keywords

CHOLESTEROL; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADD ON THERAPY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; JAPANESE; MEDICAL LITERATURE; NUTRITIONAL STATUS; REVIEW; SYSTEMATIC REVIEW;

EID: 84867708101     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.61.79     Document Type: Review

References (42)

1. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322: 1700-1707. [Medline] [CrossRef]
2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. [Medline] [CrossRef]
3. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 267-277. [Medline] [CrossRef]
4. Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H: Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: The Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb 2011; 18: 454-463. [Medline] [CrossRef]
5. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413-1419. [Medline] [CrossRef]
6. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM: Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006; 98: 1363-1368. [Medline] [CrossRef]
7. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T: Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008; 118: 2702-2709. [Medline] [CrossRef]
8. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T: High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994; 89: 2533-2539. [Medline]
9. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H: A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 1997; 28: 45-52. [Medline] [CrossRef]
10. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000; 31: 2616-2622. [Medline] [CrossRef]
11. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H: Nippon Data80 Research Group: What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253: 169-180. [Medline] [CrossRef]
12. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H, NIPPON DATA80 Research Group: The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007; 190: 216-223. [Medline] [CrossRef]
13. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, Kondo T, Watanabe Y, Koizumi A, Inaba Y, Tamakoshi A, JACC Study Group: Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 2007; 194: 415-420. [Medline] [CrossRef]
14. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis 2009; 203: 587-592. [Medline] [CrossRef]
15. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, Tanizaki Y, Ibayashi S, Iida M, Kiyohara Y: LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009; 40: 382-388. [Medline] [CrossRef]
16. Ishikawa S, Matsumoto M, Kayaba K, Gotoh T, Nago N, Tsutsumi A, Kajii E; Jichi Medical School (JMS) Cohort Study Group: Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: the JMS Cohort Study. J Epidemiol 2009; 19: 101-106. [Medline] [CrossRef]
17. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Doi M, Izumi Y, Ohta H: Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 2009; 119: 2136-2145. [Medline] [CrossRef]
18. Li Q, Morikawa Y, Sakurai M, Nakamura K, Miura K, Ishizaki M, Kido T, Naruse Y, Suwazono Y, Nakagawa H: Occupational class and incidence rates of cardiovascular events in middle aged men in Japan. Ind Health 2010; 48: 324-330. [Medline] [CrossRef]
19. Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H, Japan Arteriosclerosis Longitudinal Study Group: Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the JALS-ECC. Circ J 2010; 74: 1346-1356. [Medline] [CrossRef]
20. Nago N, Ishikawa S, Goto T, Kayaba K: Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. J Epidemiol 2011; 21: 67-74. [Medline] [CrossRef]
21. Tsuji H: Low serum cholesterol level and increased ischemic stroke mortality. Arch Intern Med 2011; 171: 1121-1123. [Medline] [CrossRef]
22. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989; 320: 904-910. [Medline] [CrossRef]
23. Lindenstrøm E, Boysen G, Nyboe J: Influence of total cholesterol, high-density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 1994; 309: 11-15. [Medline] [CrossRef]
24. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM: Lipid levels and the risk of ischemic stroke in women. Neurology 2007; 68: 556-562. [Medline] [CrossRef]
25. Prospective Studies Collaboration: Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 1829-1839. [Medline] [CrossRef]
26. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D: Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008; 52: 1769-1781. [Medline] [CrossRef]
27. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB: Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008; 39: 497-502. [Medline] [CrossRef]
28. Sasaki J, Arakawa K, Iwashita M, Matsushita Y, Kono S, Kyushu Lipid Intervention Study (KLIS) Group: Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study. Circ J 2003; 67: 473-478. [Medline] [CrossRef]
29. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006; 368: 1155-1163. [Medline] [CrossRef]
30. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559. [Medline] [CrossRef]
31. Uchiyama S, Nakaya N, Mizuno K, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Nakamura H, MEGA Study Group: Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial. J Neurol Sci 2009; 284: 72-76. [Medline] [CrossRef]
32. Cholesterol Treatment Trialists' (CTT) Collaboration: Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681. [Medline]
33. Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM, IMPROVE-IT Investigators: Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimibe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008; 156: 826-832. [Medline] [CrossRef]
34. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekekke R, Yusuf S: for Participants in the Conference on Low Cholesterol: Mortality Associations: Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046-1060. [Medline]
35. Okamura T: Low blood cholesterol and intraparenchymal hemorrhage in cohort studies. J Atheroscler Thromb 2010; 17: 312-314. [Medline] [CrossRef]
36. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461. [Medline]
37. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr 2007; 26: 121-132. [Medline]
38. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, Kagamimori S, Nakagawa H: High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: The Oyabe Study. Stroke 2003; 34: 863-839. [Medline] [CrossRef]
39. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H, NIPPON DATA90 Research Group: The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 2006; 184: 143-150. [Medline] [CrossRef]
40. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Yoshimasa Y, Okayama A: Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis 2010; 209: 290-294. [Medline] [CrossRef]
41. Laaksonen DE, Niskanen L, Nyyssönen K, Lakka TA, Laukkanen JA, Salonen JT: Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J 2008; 29: 2561-2568. [Medline] [CrossRef]
42. Toyoda K, Okada Y, Kobayashi S: Early recurrence of ischemic stroke in Japanese patients: the Japan standard stroke registry study. Cerebrovasc Dis 2007; 24: 289-295. [Medline] [CrossRef]